|
| 37683132 | Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. | JCO Oncol Pract | 2024 |
| 37994196 | Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes. | Am J Hematol | 2024 |
| 38044033 | Revisiting the first reported case of aplastic anaemia. | Br J Haematol | 2024 |
| 36260702 | An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS. | Blood Adv | 2023 |
| 38019104 | Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma. | Cancer Res Commun | 2023 |
| 37661154 | Hematoxylin: From Logwood Trees to Microscope Slides. | Mayo Clin Proc | 2023 |
| 37704469 | Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS). | Blood Rev | 2023 |
| 37934948 | Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial. | Blood Adv | 2023 |
| 37923535 | Six Decades of Philatelic Vignettes: In Honor of Dr Robert A. Kyle's Contributions to Medicine and Stamps. | Mayo Clin Proc | 2023 |
| 37086851 | Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care. | Transplant Cell Ther | 2023 |
| 37419580 | "Life Magnified:" The Beauty of the Microscopic World. | Mayo Clin Proc | 2023 |
| 37137651 | Gedeon Richter: Hungarian Pharmaceutical Pioneer and Holocaust Victim. | Mayo Clin Proc | 2023 |
| 36934059 | Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS). | Blood Rev | 2023 |
| 36868760 | Arthur Ashe, Jr: Tennis Star and AIDS and Urban Health Activist. | Mayo Clin Proc | 2023 |
| 36603953 | Gustave Roussy: Swiss-French Neurologist, Pathologist, and Cancer Institute Founder. | Mayo Clin Proc | 2023 |
| 34448437 | Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis. | Leuk Lymphoma | 2022 |
| 35787874 | Dr Li Wenliang: Wuhan "Whistleblower" and Early COVID-19 Victim. | Mayo Clin Proc | 2022 |
| 35512876 | Commercial Advertising on Postage Stamps: The Curious Case of Dr Francis Macbean Stewart's Miracle Cure. | Mayo Clin Proc | 2022 |
| 36335264 | Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms. | Leukemia | 2022 |
| 36333023 | Helen Clapesattle: Author of a Best-Selling Book About "The Doctors Mayo". | Mayo Clin Proc | 2022 |
| 36266326 | Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. | Leukemia | 2022 |
| 36058590 | Austria's Unusual Pandemic-Themed Postage Stamps: Toilet Paper, Facemask, Bandage. | Mayo Clin Proc | 2022 |
| 36153475 | The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes. | BMC Cancer | 2022 |
| 35246296 | Samuel Gridley Howe: Abolitionist, Physician, and Pioneer in Education of Children With Vision Loss and Mental Disability. | Mayo Clin Proc | 2022 |
| 35143613 | Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly "promising"? | Blood Adv | 2022 |
| 34996558 | Suzanne Gros Noël: Plastic Surgery Pioneer and Advocate for Women's Rights. | Mayo Clin Proc | 2022 |
| 34847227 | Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia. | Blood Adv | 2022 |
| 32193254 | Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells. | Haematologica | 2021 |
| 33487633 | Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? | Leukemia | 2021 |
| 33673940 | James Till and Ernest McCulloch: Hematopoietic Stem Cell Discoverers. | Mayo Clin Proc | 2021 |
| 33896620 | Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]. | Leuk Res | 2021 |
| 33705966 | A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival. | Leuk Res | 2021 |
| 33753942 | Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. | Nat Immunol | 2021 |
| 33586600 | NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation. | Leuk Lymphoma | 2021 |
| 34865699 | How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)? | Best Pract Res Clin Haematol | 2021 |
| 34736618 | M. Vera Peters: Pioneering Radiation Oncologist. | Mayo Clin Proc | 2021 |
| 34406850 | Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. | J Clin Oncol | 2021 |
| 34522041 | Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias. | Nat Immunol | 2021 |
| 34375439 | Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation. | Cancer | 2021 |
| 34481608 | Dr John H. Watson: Sherlock Holmes' Companion and Biographer. | Mayo Clin Proc | 2021 |
| 34218874 | Albin Lambotte: Pioneer of Osteosynthesis (Bone Fixation). | Mayo Clin Proc | 2021 |
| 33958073 | Emile Letournel: Pioneer of Acetabular Surgery. | Mayo Clin Proc | 2021 |
| 34172893 | Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. | Leukemia | 2021 |
| 34114922 | What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)? | Leuk Lymphoma | 2021 |
| 34253584 | Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia. | Clin Cancer Res | 2021 |
| 33220019 | Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes. | Int J Lab Hematol | 2021 |
| 33108243 | Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study. | J Clin Oncol | 2021 |
| 33449813 | Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes. | J Clin Oncol | 2021 |
| 33413841 | Kaare Nygaard: Surgeon, Scientist, Sculptor. | Mayo Clin Proc | 2021 |
| 33350168 | Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium. | Cancer Med | 2021 |